Abbott Laboratories (ABT)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 81,414,000 | 74,356,000 | 73,017,000 | 72,467,000 | 73,214,000 | 72,090,000 | 73,354,000 | 73,794,000 | 74,438,000 | 72,801,000 | 74,202,000 | 74,007,000 | 75,196,000 | 73,795,000 | 73,269,000 | 72,785,000 | 72,548,000 | 69,043,000 | 68,793,000 | 66,712,000 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $81,414,000K
= 0.00
The debt-to-assets ratio of Abbott Laboratories has consistently remained at 0.00 across various reporting periods from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized debt financing to fund its operations and investments, or that its level of debt is negligible compared to its total assets. A debt-to-assets ratio of 0.00 reflects a financially sound position, as it implies that Abbott Laboratories has a strong ability to cover its obligations using its own resources rather than relying on debt. This stability in the debt-to-assets ratio suggests that the company has a conservative debt management approach and is not overly leveraged, which can be seen as a positive sign of financial health and stability.
Peer comparison
Dec 31, 2024